A Look into Retinal Implant Industry……Deep Analysis…..
The global retinal
implant market size is expected
to reach USD 74.7 million by 2026,
according to a new report by Grand View Research, Inc. It is projected to
expand at a CAGR of 10.6% over the
forecast period. Increasing prevalence of target diseases, and rising geriatric
population are the key driving factors for the market. Rising capability of
restoring vision is anticipated to bode well for demand over the forecast
period.
Adoption of retinal implants may get impacted
due to the outbreak of the Covid-19 pandemic. It has been recorded that the
people wearing an implant and contact lens tend to touch their eyes more often
in comparison to an average person. Therefore, this can increase the risk of
virus transmission. Moreover, people who opt for a retinal implant will have to
be more cautious in order to avoid the pandemic. We are considering this
pandemic impact on our estimates. The updated report will include COVID19 as a
key market contributor.
Laser therapy and Photodynamic Therapy
(PTD) and some of the conventional treatments available for Retinitis
Pigmentosa (RP) and Age-Related Macular Degeneration (AMD). Drugs such as
Lucentis, Macugen, Eylea, and Vitamin A are a part of therapeutic treatment. Such
treatments aid in reducing disease progression and thereby, delaying blindness.
However, none of these treatments can completely cure the disease and restore
vision. As a result, treatment procedures that restore vision are highly in
demand.
Currently approved devices are capable
of restoring vision with the help of electrodes, camera chips, lenses,
software, and other tools. Moreover, implantable miniature telescope, Argus II
is easy to use and enables patients to carry out their daily activities with ease.
Furthermore, these devices can be used for a prolonged period of time,
eliminating the need for another surgery. Therefore, the capability of advanced
implantable devices to restore vision is expected to propel the market growth
in near future.
To Request Sample Copy of this report, click the link:
Increasing geriatric population and
rising disposable income in developing economies such as Japan, China, and
India are also expected to boost the retinal implant market over the forecast period.
Moreover, increasing healthcare expenditure by governments and private sectors
and initiatives by major market players to operate in untapped regions are also
anticipated to propel the growth in the forthcoming years.
Further key findings from the study
suggest:
·
In terms of revenue,
implantable miniature telescope segment is projected to expand at the highest
CAGR over the forecast period. Increasing prevalence of AMD among geriatric
population and usage of implantable devices to treat vision problems might
drive the segment’s growth over the forecast period
·
In 2026, Asia-Pacific market is
expected to witness the fastest CAGR over the forecast period owing to
increasing geriatric population and disposable income
·
VisionCare, Inc.; Retina
Implant AG; and Second Sight Medical Products, Inc. are expected to dominate
the retinal implant market over the forecast period.
The
global retinal implant market size was valued at USD 30.0 million in 2017. It
is expected to expand at a CAGR of 10.6% over the forecast period. Demand for
retinal implants is increasing due to rising prevalence of target diseases,
capability of restoring vision, and increasing geriatric population.
Researchers
are focusing on retinal prosthetics owing to the relative ease of access to the
retina for surgery. The retina has two types of photoreceptors, namely, rods
and cones. Presence of Retinitis Pigmentosa (RP), Age-Related Macular
Degeneration (AMD), or choroideremia may increase the risk of blindness with
progression of the disease.
Currently,
retinal implants are approved for the treatment of RP and end-stage AMD.
According to the Foundation Fighting Blindness, RP causes blindness in around
1.5 million people in the world. Similarly, the National Eye Institute (NIE), a
Department of National Institute of Health (NIH), states that in U.S.; the
number of people suffering from AMD was 2.1 million in 2010 and is expected to
double to reach around 5.4 million in 2050.
In
addition, according to the International Agency for the Prevention of Blindness
(IAPB), AMD is the cause of blindness in around 5.0% of global blind
population. Moreover, the same source also quotes that around 196 million
people may suffer from AMD by 2020 and the number is expected to reach
approximately 288 million in 2040. Therefore, presence of a large patient
population is expected to drive the global retinal implants market over the
forecast period.
Based
on device type, the market is segmented into retina implant alpha AMS,
implantable miniature telescope, Argus II, and others. The implantable
miniature telescope segment is expected to witness the highest CAGR over the
forecast period.
Browse Press
Release of this report:
Implantable
Miniature Telescope (IMT) was first approved in 2010, for treatment of
end-stage AMD in patients in U.S. aged 75 years and above. Furthermore, in
2014, the minimum age limit for patients eligible for receiving IMT was reduced
to 65 years and above. In addition to the U.S. Food and Drug Administration
(FDA) approval, IMT also received the CE mark, which enables Vision Care
Corporate to market the product in Europe. Moreover, Israel Ministry of Health
has approved the product for sale and distribution. Such initiatives are
anticipated to boost growth of this segment over the forecast period.
Grand View Research has segmented the
global retinal implant market on the basis of device type:
Retinal Implant Device Type Outlook (Revenue USD Million;
2014 - 2026)
·
Retina Implant Alpha AMS
·
Implantable Miniature Telescope
·
Argus II
·
Others
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of California
and headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
Comments
Post a Comment